G. BAŞARAN Et Al. , "Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study," 31st Congress of the European-Society-for-Medical-Oncology , vol.17, İstanbul, Turkey, pp.90-91, 2006
BAŞARAN, G. Et Al. 2006. Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study. 31st Congress of the European-Society-for-Medical-Oncology , (İstanbul, Turkey), 90-91.
BAŞARAN, G., Guney, N., SAİP, P. M., Iyikesici, S., Kaya, H., YAZICI, H., ... Serdar, T. N.(2006). Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study . 31st Congress of the European-Society-for-Medical-Oncology (pp.90-91). İstanbul, Turkey
BAŞARAN, Gül Et Al. "Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study," 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 2006
BAŞARAN, Gül Et Al. "Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, pp.90-91, 2006
BAŞARAN, G. Et Al. (2006) . "Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study." 31st Congress of the European-Society-for-Medical-Oncology , İstanbul, Turkey, pp.90-91.
@conferencepaper{conferencepaper, author={Gül BAŞARAN Et Al. }, title={Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study}, congress name={31st Congress of the European-Society-for-Medical-Oncology}, city={İstanbul}, country={Turkey}, year={2006}, pages={90-91} }